Metomni R XL 25/2.5 — Metoprolol Succinate IP 23

Metomni R XL 25/2.5 is a pharmaceutical product manufactured and marketed by EMK Omni Pharma, a trusted pharmaceutical company based in Mysuru, Karnataka. It belongs to the Blood Pressure Management therapeutic category and is available as a Tablet formulation.

Metomni R XL 25/2.5 by EMK Omni Pharma is a prescription-based Metoprolol Succinate SR and Ramipril Tablets formulation used for doctor-supervised blood pressure management, heart rate control, and cardiovascular health support. Each film-coated tablet contains Metoprolol Succinate IP 23.75 mg, equivalent to Metoprolol Tartrate in sustained release form, and Ramipril IP 2.5 mg. Metomni R XL 25/2.5 is commonly prescribed by healthcare professionals for patients who require support in managing hypertension, high blood pressure, cardiac workload, heart rate regulation, and long-term cardiovascular risk management. The sustained release Metoprolol component supports controlled cardiac care, while Ramipril supports physician-guided blood pressure and heart health management.

Each tablet of Metomni R XL 25/2.5 contains the following active pharmaceutical ingredients:

Active Composition: Metoprolol Succinate IP 23

Dosage Strength: 2.5 mg & 23.75 mg

Medicine Type: Tablet

Pack Size: 10 X 10 Tablets

The formulation is prepared with approved excipients to ensure optimal stability, bioavailability, and therapeutic efficacy. All ingredients comply with Indian Pharmacopoeia (IP) standards where applicable.

Metomni R XL 25/2.5 is classified under the Blood Pressure Management therapeutic category. This category encompasses medicines that are commonly prescribed by healthcare professionals for conditions related to hypertension, blood pressure control, heart rate regulation, cardiac workload reduction, and vascular health.

Metomni R XL 25/2.5 may be prescribed by doctors for patients who require support in managing high blood pressure, hypertension, elevated heart rate, cardiac strain, and cardiovascular risk factors. It may be used as part of a physician-guided heart care plan for individuals who need blood pressure control, heart rate management, and long-term cardiac health support. Metomni R XL 25/2.5 by EMK Omni Pharma is suitable for doctor-supervised treatment where blood pressure management, cardiac workload reduction, heart rate regulation, and cardiovascular support are required. Patients should not self-medicate, change the dosage, stop the medicine suddenly, chew or crush the tablet, or combine it with other medicines without consulting their doctor.

Metomni R XL 25/2.5 is formulated as a Tablet with a dosage strength of 2.5 mg & 23.75 mg. It is available in a pack size of 10 X 10 Tablets.

This product is designed for oral administration and should be taken exactly as prescribed by a registered medical practitioner. Patients should not alter the dosage, crush, chew, or break the tablet unless specifically instructed by their physician.

Important: The dosage and duration of treatment are determined by the prescribing physician based on the patient's individual medical condition, age, weight, and response to treatment.

Proper storage of pharmaceutical products is essential to maintain their quality, potency, and safety. Metomni R XL 25/2.5 should be stored according to the following guidelines:

Metomni R XL 25/2.5 Metoprolol Succinate SR and Ramipril Tablets should be stored in a cool, dry, and dark place, protected from light.

General Storage Guidelines:

• Keep the medicine in its original packaging until use
• Do not use the medicine after the expiry date printed on the packaging
• Do not store in the bathroom or near a sink
• Protect from direct sunlight, heat, and humidity
• Keep out of reach of children and pets

Metomni R XL 25/2.5 is a prescription-based pharmaceutical product. It must only be dispensed and used under the guidance of a registered medical practitioner.

Prescription Warning: Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

This medicine is regulated under Indian pharmaceutical laws and is subject to Schedule H / Schedule G drug regulations as applicable. It should not be purchased or used without a valid prescription from a licensed healthcare professional.

For Healthcare Professionals: Metomni R XL 25/2.5 is available through authorised pharmaceutical distribution channels. For product availability, pricing, and distribution enquiries, please contact EMK Omni Pharma directly.

Caution Details: The medicine must be kept out of reach of children.

General Safety Information:

• Do not self-medicate. Always consult a qualified healthcare professional before starting any new medication.
• Inform your doctor about all other medicines, supplements, or herbal products you are currently taking to avoid potential drug interactions.
• If you experience any unexpected side effects or adverse reactions, stop taking the medicine and consult your physician immediately.
• Do not share this medicine with others, even if they have similar symptoms.
• Follow the complete course of treatment as prescribed by your doctor.
• Pregnant or breastfeeding women should consult their physician before using this medicine.
• This medicine is not recommended for use in children unless specifically prescribed by a paediatrician.

EMK Omni Pharma is a trusted pharmaceutical company based in Mysuru, Karnataka, operating as Under the visionary leadership of Kumara Swamy, the company is committed to providing high-quality, physician-guided pharmaceutical products across multiple therapeutic areas.

Our product portfolio includes medicines for Cardiac Care, Cholesterol & Lipid Care, Blood Pressure Management, Nutritional Supplements, Pain Management, and Diabetes Care, all formulated to meet established pharmaceutical quality standards. EMK Omni Pharma works closely with healthcare professionals, pharmacies, hospitals, and distribution partners to ensure that quality medicines reach those who need them — safely, reliably, and responsibly.

Office Address: 2nd Floor, Room No. 01, 102A, Panchamantra Rd, above Kumar Medicals, Kuvempu Nagara, Mysuru, Karnataka 570023

Email: info@emkomnipharma.com

The information provided on this page is intended for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations.

This product information should not be used as a substitute for professional medical advice. Always consult a qualified and registered medical practitioner before starting, stopping, or changing any medication. Self-medication can be harmful and may lead to serious health consequences.

EMK Omni Pharma does not make any therapeutic claims about curing, treating, or preventing any disease without proper clinical evidence and regulatory approval. All products are intended for use only under proper medical supervision.

The product details, composition, and usage guidelines mentioned here are based on the manufacturer's product information and are subject to change. For the most current product information, please refer to the actual product packaging or consult your healthcare provider.